Bicalutamide
|
Strength |
50mg |
150mg |
||
|
Form |
Tablets |
Tablets |
||
|
Pack Size |
28 |
28 |
|
Strength |
Form |
Pack Size |
|
50mg |
Tablets |
28 |
|
150mg |
Tablets |
28 |
Bimizza
Desogestrel 150mcg/ Ethinylestradiol 20mcg
|
Strength |
150mcg/20mcg |
|||
|
Form |
Tablets |
|||
|
Pack Size |
63 |
|||
|
SmPC |
|
|||
|
Patient Leaflet |
|
|||
|
Risk Materials |
|
|||
|
Letters to HCPs |
|
|
Strength |
Form |
Pack Size |
|
150mcg/20mcg |
Tablets |
63 |
|
SmPC |
|
|
|
Patient Leaflet |
|
|
|
Risk Materials |
|
|
|
Letters to HCPs |
|
|
Buprenorphine
|
Strength |
0.4mg |
2mg | 8mg | |
|
Form |
Tablets |
Tablets | Tablets | |
|
Pack Size |
7 |
7 | 7 |
|
Strength |
Form |
Pack Size |
|
0.4mg |
Tablets |
7 |
| 2mg | Tablets | 7 |
| 8mg | Tablets | 7 |
All pictures shown are for illustration purposes only. Actual product packaging may vary.
Please refer to full SmPC text before prescribing. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Morningside Healthcare Ltd.’s Medical Information Department on Tel: 0116 478 0322.